These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27183900)

  • 1. Evidence generation from healthcare databases: recommendations for managing change.
    Bourke A; Bate A; Sauer BC; Brown JS; Hall GC
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):749-54. PubMed ID: 27183900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare databases in Europe for studying medicine use and safety during pregnancy.
    Charlton RA; Neville AJ; Jordan S; Pierini A; Damase-Michel C; Klungsøyr K; Andersen AM; Hansen AV; Gini R; Bos JH; Puccini A; Hurault-Delarue C; Brooks CJ; de Jong-van den Berg LT; de Vries CS
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):586-94. PubMed ID: 24664855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for good database selection and use in pharmacoepidemiology research.
    Hall GC; Sauer B; Bourke A; Brown JS; Reynolds MW; LoCasale R
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):1-10. PubMed ID: 22069180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies.
    Palmaro A; Moulis G; Despas F; Dupouy J; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2016 Dec; 30(6):616-624. PubMed ID: 27351637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of health care databases in pharmacoepidemiology.
    Hennessy S
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):311-3. PubMed ID: 16611207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?
    Palmaro A; Boucherie Q; Dupouy J; Micallef J; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):544-553. PubMed ID: 28266748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current needs in pediatric pharmacoepidemiology.
    Lasky T; Artaman A; Czaja AS; Maruti SS; Osokogu OU; Verhamme KM; Sobel RE
    Pharmacoepidemiol Drug Saf; 2016 Jun; 25(6):738-42. PubMed ID: 26910571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of UK clinical databases in enhancing paediatric medication research.
    Wong IC; Murray ML
    Br J Clin Pharmacol; 2005 Jun; 59(6):750-5. PubMed ID: 15948943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on drug safety and effectiveness using pharmacoepidemiological databases.
    Andersen M
    J Intern Med; 2014 Jun; 275(6):548-50. PubMed ID: 24635741
    [No Abstract]   [Full Text] [Related]  

  • 10. Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review.
    Gault N; Castañeda-Sanabria J; De Rycke Y; Guillo S; Foulon S; Tubach F
    BMC Med Res Methodol; 2017 Feb; 17(1):25. PubMed ID: 28178924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to: Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research by Lewis et al.
    van Staa TP; Parkinson J
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):103-4; author reply 104. PubMed ID: 18092305
    [No Abstract]   [Full Text] [Related]  

  • 12. Using secondary data sources for pharmacoepidemiology and outcomes research.
    Harpe SE
    Pharmacotherapy; 2009 Feb; 29(2):138-53. PubMed ID: 19170584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal detection using change point analysis in postmarket surveillance.
    Xu Z; Kass-Hout T; Anderson-Smits C; Gray G
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):663-8. PubMed ID: 25903221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies addressing inadequate information on health factors in pharmacoepidemiology studies relying on healthcare databases: commentary from a public workshop.
    Eworuke E; Shaya F; Graham DJ; Major J; Levenson M; Chen CY; Leishear K; Pinheiro S
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):998-1001. PubMed ID: 27385063
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoepidemiology.
    Evans SJ
    Br J Clin Pharmacol; 2012 Jun; 73(6):973-8. PubMed ID: 22360737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Record linkage for pharmacoepidemiological studies in cancer patients.
    Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of feasibility assessments before implementing non-interventional pharmacoepidemiologic studies of vaccines: lessons learned and recommendations for future studies.
    Willame C; Baril L; van den Bosch J; Ferreira GL; Williams R; Rosillon D; Cohet C
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1397-1406. PubMed ID: 27601179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
    Bezin J; Duong M; Lassalle R; Droz C; Pariente A; Blin P; Moore N
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):954-962. PubMed ID: 28544284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size of the reference sample in a case-augmented study.
    Ghosh P; Dewanji A
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):528-534. PubMed ID: 28295862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phynx: an open source software solution supporting data management and web-based patient-level data review for drug safety studies in the general practice research database and other health care databases.
    Egbring M; Kullak-Ublick GA; Russmann S
    Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):38-44. PubMed ID: 19777533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.